Suppr超能文献

区分帕金森病与正常状态。氟多巴F 18正电子发射断层扫描数据的判别函数分析。

Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.

作者信息

Sawle G V, Playford E D, Burn D J, Cunningham V J, Brooks D J

机构信息

MRC Cyclotron Unit, Hammersmith Hospital, London, England.

出版信息

Arch Neurol. 1994 Mar;51(3):237-43. doi: 10.1001/archneur.1994.00540150027011.

Abstract

OBJECTIVE

To explore the relationship between normal and parkinsonian fluorodopa F 18 (18F-6-L-fluorodopa [18F-dopa]) uptake data to identify clinically normal subjects who may have preclinical Parkinson's disease.

DESIGN

A statistical comparison of striatal fluorodopa F 18 positron emission tomography scan data from patients with Parkinson's disease and normal controls.

SETTING

Positron emission tomography unit within a postgraduate teaching hospital.

MAIN OUTCOME MEASURES

Discriminant function analysis used to compare the pattern of striatal (left and right caudate and putamen) fluorodopa F 18 uptake in normal subjects and patients with Parkinson's disease.

RESULTS

The discriminant score that best separates patients with Parkinson's disease from normal controls is a function of the lowest putamen influx constant minus a function of the caudate influx constant values. Borderline low normal subjects have slightly low fluorodopa F 18 uptake throughout the striatum, whereas patients with early Parkinson's disease have low fluorodopa F 18 uptake in one putamen with preserved uptake in the caudate (for normal subjects, subtracting the caudate influx constants from a function of the lowest putamen value lowers the discriminant score, although it remains positive; for patients, subtracting a larger caudate value from a function of the putamen uptake value leads to a negative score). One control subject had a borderline low discriminant score, compatible with focal nigral pathological changes as expected in preclinical Parkinson's disease. A repeated scan taken 3 years later showed a marked reduction in fluorodopa F 18 uptake, suggesting progressive nigral dysfunction.

CONCLUSION

Normal and parkinsonian fluorodopa F 18 uptake data differ both in the overall level of tracer uptake and in its spatial distribution. Subjects whose overall striatal fluorodopa F 18 uptake falls at the borderline of normal and parkinsonian values are likely to be normal if they have uniformly low uptake, but may have early or preclinical Parkinson's disease if uptake into putamen is very much lower than uptake into caudate.

摘要

目的

探讨正常人与帕金森病患者氟代多巴F 18(18F - 6 - L - 氟代多巴[18F - 多巴])摄取数据之间的关系,以识别可能患有临床前期帕金森病的临床正常受试者。

设计

对帕金森病患者和正常对照者的纹状体氟代多巴F 18正电子发射断层扫描数据进行统计学比较。

设置

一家研究生教学医院内的正电子发射断层扫描科室。

主要观察指标

采用判别函数分析比较正常受试者和帕金森病患者纹状体(左侧和右侧尾状核及壳核)氟代多巴F 18摄取模式。

结果

能最佳区分帕金森病患者与正常对照者的判别分数是最低壳核流入常数的函数减去尾状核流入常数的值的函数。临界低正常受试者整个纹状体的氟代多巴F 18摄取略低,而早期帕金森病患者一个壳核的氟代多巴F 18摄取低,尾状核摄取保留(对于正常受试者,用最低壳核值的函数减去尾状核流入常数会降低判别分数,尽管其仍为正值;对于患者,用壳核摄取值的函数减去更大的尾状核值会导致负分数)。一名对照受试者的判别分数临界低,符合临床前期帕金森病预期的局灶性黑质病理改变。3年后进行的重复扫描显示氟代多巴F 18摄取明显减少,提示进行性黑质功能障碍。

结论

正常人与帕金森病患者的氟代多巴F 18摄取数据在示踪剂摄取的总体水平及其空间分布上均存在差异。如果整个纹状体氟代多巴F 18摄取处于正常和帕金森病值的临界水平,且摄取均匀较低,则受试者可能正常,但如果壳核摄取远低于尾状核摄取,则可能患有早期或临床前期帕金森病。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验